Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GM all ... MLHP generating some interest here. Also AAPM.
Try bidding $1, see if that makes a difference lol.
Had the wrong plot checked out ... now theyre gonna get sued for destruction of proprty
Seems like they always know lol
PGNF ... gonna get alot of attention before long if it sticks with NMKT
SGCP ... Should be getting wings, wheels, everything now that there's diamonds on top of the gold. We're sitting on a diamond gold mine!!
IDGJ 1.22 ... Sort of coming to life. The news was pretty impressive.
SGCP has won the DOD (dud of the day) award for me. Announce that your sitting on $7.42/shr of gold and the price goes from .12 to .13. I know there's excavation costs and so on, but come on ... pans, shovels and mules don't cost that much!!
IFTC .04 ... Back-to-back PRs this morning ...
Press Release Source: Wavelit.com / Infotec BSI
Infotec to Announce New Revenue Model as Company Re-Brands for 2007
Wednesday December 13, 5:30 am ET
VANCOUVER, British Columbia--(BUSINESS WIRE)--With online traffic numbers beyond initial projections, Infotec (OTCBB:IFTC - News) has made a major move to take financial advantage of their international popularity. With millions of unique hits per month over the last quarter, the opportunity to capitalize on ad revenue potential at wavelit.com was too big to ignore. CEO Arthur Griffiths announced today plans to refine the current business plan and shift the company focus towards ad based revenues as opposed to user subscription revenues.
ADVERTISEMENT
As revenue projections continue to climb based on the new Galaxy Encoder 2.1 downloads, company execs were optimistic about the massive potential in moving towards an advertising revenue based model.
"With an already established audience in the millions, we are about to bring the fastest growing segment in sports online with Mixed Martial Arts. Q1 2007 looks to be a monster year for us, I can't wait!" said CEO Arthur Griffiths.
About Wavelit.com / Infotec Business Solutions, Inc.
The Internet was buzzing when Infotec BSI brought the world famous "Eagle-Cam" online. Infotec's premier website, Wavelit.com is leading the way through the internet-TV revolution. Wavelit.com, owned by Infotec Business Systems, Inc., (OTCBB:IFTC - News), offers its proprietary multi-channel, broadband full service television network under a fresh new brand, to a global audience of millions. Offering an unparalleled internet-TV experience to audiences from around the world, Infotec has fully tested its new point of presence location in the Quinby building in Los Angeles, California -- firmly establishing a foundation for the delivery of our services on a global scale. For more information, visit www.infotecbsi.com or www.wavelit.com and see what the future of online streaming is all about.
Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve uncertainties and risks that could cause actual performance and results of operations to differ materially from those anticipated by these statements. These risks and uncertainties include issues related to the ability to: obtain sufficient funding to continue operations, maintain adequate cash flow, profitably exploit new opportunities, and the unpredictable nature of business risks; as well as the ability to establish and grow brand awareness of IFTC and other factors set forth in the Company's most recently filed SEC reports. The forward-looking statements contained herein represent the Company's judgment as of the date of this release and it cautions readers not to place undue reliance on such statements. The Company assumes no obligation to update the statements contained in this release.
Contact:
Wavelit.com / Infotec BSI
CEO
Arthur Griffiths, 604-682-1442
a.griffiths@infotecbsi.com
or
Investor Relations
invest@infotecbsi.com
--------------------------------------------------------------------------------
Source: Wavelit.com / Infotec BSI
Press Release Source: Wavelit.com / Infotec BSI
Infotec To Expand with AOL Affiliate Ad Giants Advertising.com
Wednesday December 13, 5:30 am ET
VANCOUVER, British Columbia--(BUSINESS WIRE)--On the heels of the recent announcement of Infotec's new advertising-based revenue focus for 2007, another major deal was released by CEO Arthur Griffiths today. An agreement has been reached with wholly-owned AOL subsidiary advertising.com, among several other internet marketing giants, to deliver advertising content to Infotec's premier website www.wavelit.com . Advertising.com is considered the #1 online advertising network site, holding the largest online market share to date. Taking full advantage of their vast advertising client base and network, Infotec is keen to publish some of the world's top online ads and beat profit projections. As Valueclick.com nears completion of their own unique agreement with Infotec, CEO Arthur Griffiths is focused on working with only the best in online advertising.
ADVERTISEMENT
Providing quality online media solutions to advertisers, Casale has also secured an agreement with Infotec to further develop the advertising potential of www.wavelit.com with their own online network. Both Advertising.com and Casale are considered to be among the best names in online advertising, a major coup for Infotec. With 3 power-house Internet advertising brands in line with Infotec, Griffith's move towards an ad-based revenue model seems timelier than ever.
"When our web traffic numbers blew both our quarterly goals, and projections out of the water, I knew we had made the right move towards a more profitable revenue model. To be working with Advertising.com and Casale is a massive leap forward for us, and I'm more optimistic than ever to as the New Year approaches," said CEO Arthur Griffiths.
About Wavelit.com / Infotec Business Solutions, Inc.
The Internet was buzzing when Infotec BSI brought the world famous "Eagle-Cam" online. Infotec's premier website, Wavelit.com is leading the way through the internet-TV revolution. Wavelit.com, owned by Infotec Business Systems, Inc., (OTCBB: IFTC.OB - News), offers its proprietary multi-channel, broadband full service television network under a fresh new brand, to a global audience of millions. Offering an unparalleled internet-TV experience to audiences from around the world, Infotec has fully tested its new point of presence location in the Quinby building in Los Angeles, California - firmly establishing a foundation for the delivery of our services on a global scale. For more information, visit www.infotecbsi.com or www.wavelit.com and see what the future of online streaming is all about.
Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve uncertainties and risks that could cause actual performance and results of operations to differ materially from those anticipated by these statements. These risks and uncertainties include issues related to the ability to: obtain sufficient funding to continue operations, maintain adequate cash flow, profitably exploit new opportunities, and the unpredictable nature of business risks; as well as the ability to establish and grow brand awareness of IFTC and other factors set forth in the Company's most recently filed SEC reports. The forward-looking statements contained herein represent the Company's judgment as of the date of this release and it cautions readers not to place undue reliance on such statements. The Company assumes no obligation to update the statements contained in this release.
Contact:
Wavelit.com / Infotec BSI
CEO Arthur Griffiths, a.griffiths@infotecbsi.com
Investor Relations, invest@infotecbsi.com
Phone: 604-682-1442
--------------------------------------------------------------------------------
Source: Wavelit.com / Infotec BSI
Another PR tomorrow will definitely finish them off
OT ... Along similar lines (sort of), if someone could develop biomarkers for penny stocks that have NO life, that would be a great investment.
Portable Analyzer Is Powerful Tool for Detecting Biomarkers of Life on Mars
Business Wire - December 12, 2006 11:48
NEW ROCHELLE, N.Y., Dec 12, 2006 (BUSINESS WIRE) -- The Mars Organic Analyzer (MOA), a portable capillary electrophoresis instrument, combined with state-of-the-art fluorescent labeling technology, can detect a much broader spectrum of organic compounds than was previously possible, and these could serve as key biomarkers of extinct or existing life on Mars, according to a report in the December 2006 issue (Volume 6, Number 6) of Astrobiology, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The report is available free online at www.liebertpub.com/ast
Recent observations based on the findings of remote sensing devices and robotic probes that have explored the martian surface suggest that liquid water is, or at least was at some time present on Mars. This has revitalized efforts to search for evidence of extinct or existing life forms. Critical to this effort is the availability of highly sensitive instruments capable of detecting very small quantities of the building blocks or degradation products of microbial life forms.
Alison Skelley, H. James Cleaves, Christine Jayarajah, Jeffrey Bada, and Richard Mathies, from the University of California, Berkeley, and the Scripps Institution of Oceanography at the University of California at San Diego, demonstrated that the microchip capillary electrophoresis (CE)-based Mars Organic Analyzer was able to detect and analyze with high sensitivity a greatly expanded range of target analytes, in a paper entitled, "Application of the Mars Organic Analyzer to Nucleobase and Amine Biomarker Detection."
The authors compared different extraction techniques--including hydrolysis and sublimation--to isolate analytes from bacteria. They utilized fluorescamine labeling to identify amine-containing biomarker compounds, including amino acids, amino sugars, and nucleobases.
"The group's success in applying the MOA to the analysis of a wider variety of organic biomarker compounds is an important advancement of this component of the Urey Instrument, which is being developed for the ESA ExoMars Mission scheduled to launch in 2013," says journal Editor-in-Chief, Sherry L. Cady, Ph.D., Associate Professor in the Department of Geology at Portland State University. To learn more about the groups efforts to find life on Mars, visit their website at http://astrobiology.berkeley.edu.
Astrobiology is the leading peer-reviewed journal in its field. To promote this developing field, the Journal has teamed up with The Astrobiology Web to highlight one outstanding paper per issue of Astrobiology. This paper is available free online at www.liebertpub.com/ast and to visitors of The Astrobiology Web at www.astrobiology.com
Astrobiology is an authoritative peer-reviewed journal published quarterly in print and online. The Journal provides a forum for scientists seeking to advance our understanding of life's origins, evolution, distribution and destiny in the universe. Table of contents and a free sample issue may be viewed online at www.liebertpub.com/ast
Mary Ann Liebert, Inc., is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research. Its biotechnology trade magazine, Genetic Engineering News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 60 journals, books, and newsmagazines is available at www.liebertpub.com
SOURCE: Mary Ann Liebert, Inc.
I'll bet he bought it so fast it hadn't even been put up for sale yet. Haha just kidding JJ, you keep doing what you're doing, makes trading easier for us members of the over-the-hill gang.
LESS than a minute, yes, and responds to msgs in LESS than 2 minutes at the same time!! Probly placed a half-dozen trades in the meantime while having breakfast hoho. Keep up the good work JJ and someday you'll be rewarded!!
GHTI ... Posted here by JJ within 1 minute per my Ameritrade Streamer time. Now if that doesn't give folks here the edge, I don't know what does. Another great job of reporting the news JJ!!!!!!!!!!
PGNF .0275 ... should be trading higher on news with NMKT announced last week. Was .065 wednesday.
GHTI projects 100% increase in '07 revenues.
SLJB ... expect to have a stellar day after recent activity.
I said I wasn't going to post any more to this board, but ... your letter signed "Your Shareholders" represents libel on your part, because there are many of us shareholders who don't agree with the letter so don't be putting words in our mouths. I believe it was just a week ago that you and the HOG returned from your trip with such a glowing report. And now you've changed your mind again and decided that the company's what, a scam, based on its not responding in the way that you think it should? I haven't followed the posts that closely, but if you are changing course so easily, if you're so wishy-washy, I believe you completely lack credibility, and need to step down as one of the moderators.
DNAG next leg starting
BCLC .0011 ... has been to .0016 already this morn, good entry.
DNAG ... I see .03 in past 12 mos.
http://www.pinksheets.com/quote/chart.jsp?symbol=DNAG&duration=2-6-9-0-0-512
DNAG volume staggering ... above 52-week high already!!
BCLC coming back strong .... I believe TOON called this wednesday, congrats.
MLHP looks pretty inviting after news .... where there's Millenia there's Hope.
Time to buy PGNF again ... don't forget NMKT Latin American ops ... $20 mil revs.
DNAG on cruise control this morning thanks to healthier mice.
NMKT ... has anybody else noticed that NMKT has been out of control recently? They're taking over the world imho.
DNAG up 25% on whopping volume. Yes whopping volume. HOD too.
MLHP ... Looking good ...
Press Release Source: MILLENIA HOPE BIOPHARMA
State of the Corporation - A Message from the President and Chief Scientific Officer, Dr. Bahige M. Baroudy
Friday December 8, 8:30 am ET
MONTREAL, QC and WILMINGTON, DE, Dec. 8 /PRNewswire-FirstCall/ -
Dear Shareholders,
For Millenia Hope (OTC:BB MLHP, Frankfurt-MLF), 2006 was a year dedicated to strategic planning to meet new challenges, to show tangible bottom line results and to foster a business environment conducive to the creation of great shareholder value. By examining our inventory of products and assessing the elements necessary to increase shareholder value, we made a firm commitment to diversification and the broadening of our product base. This led to our acquisitions, which we believe will help us fulfill our business plan in the short, medium and long term.
I would like to summarize the activities and events which occurred in the company over the past twelve months and which I feel place our company in an enviable position in the marketplace:
In early 2006, Millenia Hope's subsidiary corp. acquired the assets of a biopharma company, which included patents and patents pending, 5 million dollars (original cost) worth of scientific equipment, nine years of scientific research and development expertise and a library of 160,000 highly purified fractions from 2,200 plant species. Currently operating under the name of Millenia Hope Biopharma (MHB), it is among the top Phytomics Technology companies in the world.
Since the initial acquisition, MHB has concluded a breakthrough contract, with one of the world's largest cosmetic companies, an important Phase I contract, with a billion dollar international pharma (Les Medicaments Pierre Fabre), is in negotiations with eight more corporations and is in the final stages of concluding a multi-million dollar, multi-year contract with an international consumer giant. This strategic move placed MLHP on a new and elevated playing field; ownership of a diverse set of highly sought after products and patents, as an example: a major plant cell culture discovery and development - parthenolide-free feverfew, an ongoing revenue stream generated from some of the global leaders in their fields, top notch research facilities and enhanced scientific expertise leading to new discoveries and additional patents and patent applications. This ramified scientific infrastructure provides us with the opportunity to disseminate our unique technology globally, targeting the cosmetics, neutriceutical and pharmaceutical industries. In the near term we perceive that our specialized expertise will make us the company of choice in these three important market sectors, whose combined annual sales are in the hundreds of billions of dollars.
MHB's new research and development facility is located in the center of Montreal's pharmaceutical industry and provides us with better access to the trained pharmaceutical staff and the additional high quality space needed to expand manufacturing.
The building has 34,000 sq ft of space of which 12,000 sq ft is manufacturing clean space, 2,000 sq ft is laboratory and 10,000 sq ft is office space. We would like to thank the people of Loblaw for their support of biotech companies, a rarity in Quebec.
Millenia Hope Biopharma has filed an SB-2 with the SEC, pursuant to becoming a public reporting company. MHB has also contracted with a national securities firm, Union Securities, to act as the lead underwriter for a $10 million convertible debenture, earning the investor 10% per year. It is envisioned that this, private placement, will be followed by a listing on the TSX and/ or European or overseas exchange and an IPO.
Millenia has put in place a program to treat major infectious diseases that impact global health and is currently developing treatments for Malaria and HIV/AIDS, two major diseases that continue to be a global challenge as resistance to existing drugs mounts.
Heenan Blaikie, a prestigious Canadian law firm, led in this undertaking by the Rt. Honourable, former Prime Minister of Canada Jean Chretien, a senior - Heenan partner, has teamed up with Millenia Hope in its crusade against malaria. Via their diligent efforts, Millenia is working on forging joint ventures to build manufacturing facilities and distribution centers, for its anti-malaria drug, MalarexMMH(TM)18, in 2 African countries. As a result of this crusade, Millenia has signed an MOU with Suninvest of Angola as a partner for this facility. These contracts will be signed directly with the governments of those countries and represent a major milestone in Millenia's quest to alleviate the human suffering and devastation caused by malaria in Africa and other regions of the world.
Millenia signed an agreement with the Pasteur Institute of Cote D'Ivoire, who will act in an oversight and regulatory capacity in Cote D'Ivoire. The overall objective is the eventual eradication of infectious diseases, initially focusing on Malaria and HIV.
We have also expanded our horizons to the East (China) by signing, with HolleyPharm Group, a Memorandum of Understanding to collaborate on the development of a series of new plant-based products, for the pharmaceutical and herbal markets, using the resources of the two companies.
Thank you for your ongoing financial support and patience. On behalf of my colleagues, at Millenia Hope, let me wish all of you a Happy Holiday Season!
Safe Harbor Statement:
Certain statements made in this release may contain language describing the plans, goals, strategies, intentions, forecasts and expectations of Millenia Hope that may be referred to as "forward-looking statements." Several important factors could cause actual results to differ materially from those in such forward-looking statements, and Millenia Hope could encounter unanticipated obstacles and delays in developing products, services and markets.
--------------------------------------------------------------------------------
Source: MILLENIA HOPE BIOPHARMA
DNAG Dip and Go
MLHP has alot going on ...
Press Release Source: MILLENIA HOPE BIOPHARMA
State of the Corporation - A Message from the President and Chief Scientific Officer, Dr. Bahige M. Baroudy
Friday December 8, 8:30 am ET
MONTREAL, QC and WILMINGTON, DE, Dec. 8 /PRNewswire-FirstCall/ -
Dear Shareholders,
For Millenia Hope (OTC:BB MLHP, Frankfurt-MLF), 2006 was a year dedicated to strategic planning to meet new challenges, to show tangible bottom line results and to foster a business environment conducive to the creation of great shareholder value. By examining our inventory of products and assessing the elements necessary to increase shareholder value, we made a firm commitment to diversification and the broadening of our product base. This led to our acquisitions, which we believe will help us fulfill our business plan in the short, medium and long term.
I would like to summarize the activities and events which occurred in the company over the past twelve months and which I feel place our company in an enviable position in the marketplace:
In early 2006, Millenia Hope's subsidiary corp. acquired the assets of a biopharma company, which included patents and patents pending, 5 million dollars (original cost) worth of scientific equipment, nine years of scientific research and development expertise and a library of 160,000 highly purified fractions from 2,200 plant species. Currently operating under the name of Millenia Hope Biopharma (MHB), it is among the top Phytomics Technology companies in the world.
Since the initial acquisition, MHB has concluded a breakthrough contract, with one of the world's largest cosmetic companies, an important Phase I contract, with a billion dollar international pharma (Les Medicaments Pierre Fabre), is in negotiations with eight more corporations and is in the final stages of concluding a multi-million dollar, multi-year contract with an international consumer giant. This strategic move placed MLHP on a new and elevated playing field; ownership of a diverse set of highly sought after products and patents, as an example: a major plant cell culture discovery and development - parthenolide-free feverfew, an ongoing revenue stream generated from some of the global leaders in their fields, top notch research facilities and enhanced scientific expertise leading to new discoveries and additional patents and patent applications. This ramified scientific infrastructure provides us with the opportunity to disseminate our unique technology globally, targeting the cosmetics, neutriceutical and pharmaceutical industries. In the near term we perceive that our specialized expertise will make us the company of choice in these three important market sectors, whose combined annual sales are in the hundreds of billions of dollars.
MHB's new research and development facility is located in the center of Montreal's pharmaceutical industry and provides us with better access to the trained pharmaceutical staff and the additional high quality space needed to expand manufacturing.
The building has 34,000 sq ft of space of which 12,000 sq ft is manufacturing clean space, 2,000 sq ft is laboratory and 10,000 sq ft is office space. We would like to thank the people of Loblaw for their support of biotech companies, a rarity in Quebec.
Millenia Hope Biopharma has filed an SB-2 with the SEC, pursuant to becoming a public reporting company. MHB has also contracted with a national securities firm, Union Securities, to act as the lead underwriter for a $10 million convertible debenture, earning the investor 10% per year. It is envisioned that this, private placement, will be followed by a listing on the TSX and/ or European or overseas exchange and an IPO.
Millenia has put in place a program to treat major infectious diseases that impact global health and is currently developing treatments for Malaria and HIV/AIDS, two major diseases that continue to be a global challenge as resistance to existing drugs mounts.
Heenan Blaikie, a prestigious Canadian law firm, led in this undertaking by the Rt. Honourable, former Prime Minister of Canada Jean Chretien, a senior - Heenan partner, has teamed up with Millenia Hope in its crusade against malaria. Via their diligent efforts, Millenia is working on forging joint ventures to build manufacturing facilities and distribution centers, for its anti-malaria drug, MalarexMMH(TM)18, in 2 African countries. As a result of this crusade, Millenia has signed an MOU with Suninvest of Angola as a partner for this facility. These contracts will be signed directly with the governments of those countries and represent a major milestone in Millenia's quest to alleviate the human suffering and devastation caused by malaria in Africa and other regions of the world.
Millenia signed an agreement with the Pasteur Institute of Cote D'Ivoire, who will act in an oversight and regulatory capacity in Cote D'Ivoire. The overall objective is the eventual eradication of infectious diseases, initially focusing on Malaria and HIV.
We have also expanded our horizons to the East (China) by signing, with HolleyPharm Group, a Memorandum of Understanding to collaborate on the development of a series of new plant-based products, for the pharmaceutical and herbal markets, using the resources of the two companies.
Thank you for your ongoing financial support and patience. On behalf of my colleagues, at Millenia Hope, let me wish all of you a Happy Holiday Season!
Safe Harbor Statement:
Certain statements made in this release may contain language describing the plans, goals, strategies, intentions, forecasts and expectations of Millenia Hope that may be referred to as "forward-looking statements." Several important factors could cause actual results to differ materially from those in such forward-looking statements, and Millenia Hope could encounter unanticipated obstacles and delays in developing products, services and markets.
--------------------------------------------------------------------------------
Source: MILLENIA HOPE BIOPHARMA
DNAG running on news
DNAG to run today ... BIG NEWS
PGNF ... Still way undervalued according to Latin American revenues
NCII all over the place today ... way up ... down ... up again
NMKT ... Remember the PGNF link to NMKT ... PGNF is at bargain basement now compared to last week when it announced agreement with NMKT for Latin American operations.
PLYCF ... There was a time to buy, but lately it's been 2 steps forward and 7 steps back. Wouldn't bother promoting it til there's something serious going on.
GLXI ... Bot it a few days ago ... look at the chart, lots of room to roam.
http://www.pinksheets.com/quote/chart.jsp?symbol=glxi
PGNF .025 should get back in play with NMKT. PGNF was over .06 a few days back on LOI for NMKT Latin American operations.
MLHP ... There you go again. Dang ... downright lightning-fast.